Literature DB >> 35997659

Identifying Chronic Pain Subgroups in Pediatric Sickle Cell Disease: A Cluster-Analytic Approach.

Soumitri Sil1,2, Alison Manikowski3,2, Mallory Schneider3,2, Lindsey L Cohen2,4, Carlton Dampier1,2.   

Abstract

OBJECTIVES: Youth with sickle cell disease (SCD) and chronic pain, defined in this study as pain on most days for 3 months, experience variability in daily pain and physical and psychosocial functioning. This study aimed to (1) empirically derive chronic pain subgroups based on pain characteristics among youth with chronic SCD pain; and (2) investigate derived subgroups for differences in sociodemographics, clinical characteristics, and psychosocial and functional outcomes.
MATERIALS AND METHODS: Youth with chronic SCD pain (n=62, Mage =13.9, SD=2.5, 10 to 18 y; 58% female, 60% HbSS) completed a battery of questionnaires. Clinical characteristics (eg, medications, treatments) and health care utilization were abstracted from electronic medical records. Hierarchical cluster analysis informed the number of clusters at the patient level. k-means cluster analysis used multidimensional pain assessment to identify and assign patients to clusters.
RESULTS: Cluster 1 (n=35; Moderate Frequency, Moderate Pain) demonstrated significantly lower worst pain intensity, number of pain days per month, number of body sites affected by pain, and pain quality ratings. Cluster 2 (n=27; Almost Daily, High Pain) reported high ratings of worst pain intensity, almost daily to daily pain, greater number of body sites affected by pain, and higher ratings of pain quality (all P 's <0.05). There were no differences between subgroups by sociodemographics, clinical characteristics, or health care utilization. The Almost Daily, High Pain subgroup reported significantly higher pain interference, depressive symptoms, and pain catastrophizing than the Moderate Frequency, Moderate Pain subgroup. DISCUSSION: Identifying chronic SCD pain subgroups may inform tailored assessment and intervention to mitigate poor pain and functional outcomes.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35997659      PMCID: PMC9481686          DOI: 10.1097/AJP.0000000000001065

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.423


  62 in total

1.  AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain.

Authors:  Carlton Dampier; Tonya M Palermo; Deepika S Darbari; Kathryn Hassell; Wally Smith; William Zempsky
Journal:  J Pain       Date:  2017-01-05       Impact factor: 5.820

2.  Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.

Authors:  Carlton Dampier; Beth Ely; Darcy Brodecki; Camille Coleman; Leela Aertker; Jocelyn Andrel Sendecki; Benjamin Leiby; Karen Kesler; Terry Hyslop; Marie Stuart
Journal:  Pediatr Blood Cancer       Date:  2013-09-24       Impact factor: 3.167

3.  Disclosure and self-report of emotional, social, and physical health in children and adolescents with chronic pain--a qualitative study of PROMIS pediatric measures.

Authors:  C Jeff Jacobson; Jennifer E Farrell; Susmita Kashikar-Zuck; Michael Seid; Emily Verkamp; Esi Morgan Dewitt
Journal:  J Pediatr Psychol       Date:  2012-09-30

4.  Psychological, behavioral, and family characteristics of pediatric patients with chronic pain: a 1-year retrospective study and cluster analysis.

Authors:  Lisa Scharff; Nicole Langan; Nancy Rotter; Jennifer Scott-Sutherland; Clorinda Schenck; Neil Tayor; Lori McDonald-Nolan; Bruce Masek
Journal:  Clin J Pain       Date:  2005 Sep-Oct       Impact factor: 3.442

5.  Impact of pain on the course of depressive and anxiety disorders.

Authors:  Marloes M J G Gerrits; Nicole Vogelzangs; Patricia van Oppen; Harm W J van Marwijk; Henriette van der Horst; Brenda W J H Penninx
Journal:  Pain       Date:  2011-12-10       Impact factor: 6.961

6.  Somatosensory nociceptive characteristics differentiate subgroups in people with chronic low back pain: a cluster analysis.

Authors:  Martin Rabey; Helen Slater; Peter O'Sullivan; Darren Beales; Anne Smith
Journal:  Pain       Date:  2015-10       Impact factor: 6.961

Review 7.  NeuPSIG guidelines on neuropathic pain assessment.

Authors:  Maija Haanpää; Nadine Attal; Miroslav Backonja; Ralf Baron; Michael Bennett; Didier Bouhassira; Giorgio Cruccu; Per Hansson; Jennifer A Haythornthwaite; Gian Domenico Iannetti; Troels S Jensen; Timo Kauppila; Turo J Nurmikko; Andew S C Rice; Michael Rowbotham; Jordi Serra; Claudia Sommer; Blair H Smith; Rolf-Detlef Treede
Journal:  Pain       Date:  2010-09-19       Impact factor: 6.961

8.  Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers.

Authors:  Esi M Morgan; Constance A Mara; Bin Huang; Kimberly Barnett; Adam C Carle; Jennifer E Farrell; Karon F Cook
Journal:  Qual Life Res       Date:  2016-12-02       Impact factor: 4.147

9.  Examination of risk and resiliency in a pediatric sickle cell disease population using the psychosocial assessment tool 2.0.

Authors:  Cynthia W Karlson; Stacey Leist-Haynes; Maria Smith; Melissa A Faith; T David Elkin; Gail Megason
Journal:  J Pediatr Psychol       Date:  2012-07-26

10.  Parent factors and adolescent sickle cell disease: associations with patterns of health service use.

Authors:  Deirdre E Logan; Jerilynn Radcliffe; Kim Smith-Whitley
Journal:  J Pediatr Psychol       Date:  2002 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.